DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 213 filers reported holding DEPOMED INC in Q3 2016. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $6,280,000 | -28.8% | 348,480 | -1.3% | 0.10% | -34.9% |
Q3 2016 | $8,815,000 | +26.3% | 353,030 | -0.7% | 0.15% | +22.7% |
Q2 2016 | $6,977,000 | +39.7% | 355,630 | -0.8% | 0.12% | +22.7% |
Q1 2016 | $4,993,000 | -23.3% | 358,430 | -0.2% | 0.10% | -30.2% |
Q4 2015 | $6,513,000 | +5.9% | 359,230 | +30.9% | 0.14% | -29.1% |
Q1 2015 | $6,152,000 | +38.7% | 274,500 | -0.3% | 0.20% | +22.5% |
Q4 2014 | $4,437,000 | +7.7% | 275,400 | +1.5% | 0.16% | -9.6% |
Q3 2014 | $4,121,000 | +9.3% | 271,300 | 0.0% | 0.18% | +10.6% |
Q2 2014 | $3,771,000 | -15.7% | 271,300 | -12.1% | 0.16% | -25.9% |
Q1 2014 | $4,475,000 | +22.6% | 308,600 | -10.5% | 0.22% | +7.5% |
Q4 2013 | $3,649,000 | +38.1% | 344,900 | -2.5% | 0.20% | +27.2% |
Q3 2013 | $2,642,000 | +30.9% | 353,700 | -1.5% | 0.16% | +11.3% |
Q2 2013 | $2,018,000 | – | 359,000 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 2,252,402 | $31,376,000 | 7.88% |
Healthcare Value Capital, LLC | 350,000 | $4,876,000 | 7.16% |
Senvest Management, LLC | 4,977,256 | $69,333,000 | 5.82% |
Consonance Capital Management LP | 2,756,360 | $38,396,000 | 5.81% |
Opaleye Management Inc. | 325,000 | $4,527,000 | 2.82% |
Krensavage Asset Management, LLC | 447,000 | $6,227,000 | 2.23% |
Healthcare Value Capital, LLC | 100,000 | $1,393,000 | 2.05% |
Starboard Value LP | 2,950,000 | $41,094,000 | 1.44% |
HealthInvest Partners AB | 200,000 | $2,786,000 | 1.30% |
OAK RIDGE INVESTMENTS LLC | 7,206,286 | $100,384,000 | 1.29% |